12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday’s after-market session. The market value…
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 160 companies set new 52-week lows.
Oppenheimer Maintains Outperform on Jasper Therapeutics, Lowers Price Target to $8
Oppenheimer analyst Jay Olson maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the price target from $21 to $8.
EF Hutton Initiates Coverage On Jasper Therapeutics with Buy Rating, Announces Price Target of $4
EF Hutton analyst Michael King initiates coverage on Jasper Therapeutics (NASDAQ:JSPR) with a Buy rating and announces Price Target of $4.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
Important Biotech Catalysts For September 15, 2022 – End Of The Day Summary
Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity…
Jasper Therapeutics Announces FDA Fast Track Designation For JSP191
JSP191 is currently being evaluated in four ongoing clinical studies in allogeneic hematopoietic stem cell transplant in patients with Acute Myeloid Leukemia (AML) / Myelodysplastic Syndromes (MDS), SCID, Fanconi